Across TCGA pan-cancer cohorts, RNU1-151P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU1-151P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU1-151P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU1-151P is over-expressed in tumor, although a few such as ESCA and STAD show the opposite, repressed pattern.

KIRC, ESCA, and STAD are the cancer types where RNU1-151P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU1-151P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.058	.011	4	view →
ESCA	All	All	−1.688	.012	1	view →
STAD	Male	IV	−0.645	<.001	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU1-151P RNA expression & survival · all RNU1-151P data types